Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
26.9 EUR | +2.67% |
|
0.00% | +40.43% |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- The company shows low valuation levels, with an enterprise value at 0.52 times its sales.
- The company's share price in relation to its net book value makes it look relatively cheap.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- For the past twelve months, EPS forecast has been revised upwards.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Analyst opinion has improved significantly over the past four months.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- The company does not generate enough profits, which is an alarming weak point.
- The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Sector: Life & Health Insurance
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+40.43% | 26.94B | - | ||
+7.97% | 77.31B | B- | ||
+13.18% | 53.05B | B | ||
+12.55% | 52.93B | B+ | ||
+26.50% | 48.37B | B+ | ||
+21.05% | 45.08B | B+ | ||
+22.17% | 39.43B | B | ||
+18.33% | 33.46B | B | ||
+42.08% | 29.24B | A | ||
+0.42% | 29.21B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 8750 Stock
- QHH Stock
- Ratings Dai-ichi Life Holdings, Inc.